Summary

Report Scope
The current report provides detailed information about the market’s implantable remote patient monitoring (IRPM) devices. It provides market projections through 2029 and market ranks for key players. The report details the market share of IRPM devices based on product, indication and end users. This market is segmented into implantable cardiovascular monitoring devices, implantable brain monitoring devices, gastrointestinal monitoring (smart pills), implantable hematological monitoring devices, implantable respiratory monitoring devices, implantable musculoskeletal monitoring devices and others based on product. Based on indication, the market is segmented into cardiovascular diseases, brain disorders, gastrointestinal diseases, diabetes, chronic respiratory diseases, musculoskeletal diseases, and others. By end user, the market is categorized into hospitals and clinics, home healthcare settings, and others. A detailed competitive landscape includes major players, market share and recent strategic developments.
Additionally, the report offers a regional analysis, breaking down market trends and growth prospects across different geographical areas. It includes market forecasts, consumer insights, and a thorough supply chain analysis, addressing distribution channels and key suppliers. By examining these elements, the report aims to provide a comprehensive view of the market’s current state and future potential, assisting stakeholders in making well-informed decisions and identifying strategic opportunities within the IRPM devices industry.
Report Includes
- 32 data tables and 47 additional tables
- An overview of the global market for implantable remote patient monitoring (IRPM) devices
- Analyses of the global market trends, with sales data for 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
- Estimates of the market size and revenue forecast for the global market, and a corresponding market share analysis by product, indication, end user, and region
- Discussion of the underlying opportunities in the implantable remote patient monitoring devices market, with the integration of internet of things (IoT) and wireless technologies for the diagnosis and treatment of diseases
- Assessment of factors driving the industry’s growth, current trends, market opportunities and restraints, and the technological advances that will shape the future market
- Market share analysis of the major global corporations, the competitive landscape, product developments, marketing strategies and revenue forecasts
- A discussion of the industry’s ESG challenges and practices
- Emphasis on the increasingly stringent government regulations as well as the increasing adoption of miniaturized multi-sensing devices in chronic disease management and self-health management
- Latest information on mergers and acquisitions, partnerships, agreements, collaborations, and other strategic alliances
- Identification of the major stakeholders and analysis of recent developments and segmental revenues
- Profiles of the leading companies, including Boston Scientific Corp., Medtronic, Abbott Laboratories, Dexcom Inc., and Biotronik

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Overview
PESTEL Analysis
Political
Economic
Social
Technological
Environmental
Legal
Porter's Five Forces Analysis
Bargaining Power of Buyers
Bargaining Power of Suppliers
Potential for New Entrants
Threat of Substitutes
Competition in the Industry
Supply Chain Analysis
R&D, Product Design and Early Prototyping
Regulatory Submissions and Approvals
Raw Material Procurement
Manufacturing IRPM Devices
Distribution and Sales
Post-Sales Services
Chapter 3 Market Dynamics
Market Dynamics Overview
Market Drivers
Increasing Prevalence of Chronic Diseases and an Aging Population
Growing Demand for mHealth Applications
Improved Wireless Communication Technologies
Market Restraints
Data Privacy Concerns
Stringent Government Regulations
Market Opportunities
Emerging Markets
Market Challenges
Integration with Healthcare Systems
Chapter 4 Regulatory Landscape
Regulatory Framework
United States
European Union
Japan
Chapter 5 Emerging Technologies and Developments
Emerging Technologies in the IRPM Devices Market
Artificial Intelligence and Machine Learning
Nanotechnology-based Devices
Biocompatible Materials
Patent Analysis
Patents by Year
Patents by Top Applicant
Patents by Top Owner
Patents by Top Inventor
Patents by Jurisdiction
Chapter 6 Market Segment Analysis
Segmentation Breakdown
IRPM Devices: Global Markets
Market Analysis by Product
Implantable Cardiovascular Monitoring Devices
Implantable Brain Monitoring Devices
Gastrointestinal Monitoring (Smart Pills)
Implantable Hematological Monitoring Devices
Implantable Respiratory Monitoring Devices
Implantable Musculoskeletal Monitoring Devices
Others
Market Analysis by Indication
Cardiovascular Diseases
Brain Disorders
Gastrointestinal Diseases
Diabetes
Chronic Respiratory Diseases
Musculoskeletal Diseases
Others
Market Analysis by End User
Hospital and Clinics
Home Healthcare Settings
Other End-users
Geographic Breakdown
Market Analysis by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 7 Sustainability: An ESG Perspective in IRPM Devices
Sustainability in the IRPM Devices Industry
Understanding the ESG Data
Concluding Remarks from BCC
Chapter 8 Competitive Intelligence
Overview
Key Strategies for IRPM Devices Manufacturers
Distribution Networks
Product Mapping
Chapter 9 Appendix
Methodology
Abbreviations
Sources
Company Profiles
ABBOTT
AVERTIX MEDICAL INC.
BIOTRONIK
BOSTON SCIENTIFIC CORP.
CARDIAC RMS
DEXCOM INC.
EBR SYSTEMS INC.
ENDOTRONIX INC.
INJECTSENSE INC.
IMPULSE DYNAMICS
MEDICO S.R.L.
MEDTRONIC
PROFUSA INC.
QURA LLC.
VITALCONNECT